Pan-Canadian Pharmaceutical Alliance

• B.C. government funds new drug for people with spinal muscular atrophy

  The annual cost of the medication — called risdiplam or Evrysdi — is between $93,456 and $354,000 depending on the age and weight of the patient. 

  Health

  Feb 15, 2022
  
• Cystic fibrosis life-altering drug nearing patient access across the country: Health Canada

  Medical experts feel Trikafta should be available in most, if not all the provinces, by Labour Day. This would mean cystic fibrosis patients would have full access.

  Health

  Jun 20, 2021
  
• Advertisement
• Kaysen Martin’s family frustrated as they await decision on $2.8M drug coverage

  The mother of two-year-old Kaysen Martin says it's unrealistic for her family to raise the $2.8 million needed for her son's drug coverage.

  Health

  Jul 24, 2020
• Advertisement
• Saskatoon family waiting for access to cystic fibrosis treatments

  A Saskatoon family waits on a potential deal that would bring access to new cystic fibrosis treatment drugs in Canada that would help their two boys who have CF.

  Canada

  Jun 28, 2020
• Alberta pharmacists turn to social media to spread word about drug shortages

  The owner of a Medicine Shoppe in Sherwood Park says pharmacists are seeing widespread shortages across just about every category of prescription medicine required.

  Canada

  Nov 23, 2018
• Calgary family asking AHS to cover cost of drug that could save son’s life

  It's a drug that could be life-saving for a 10-year-old Calgary boy. The problem is his family and dozens of others in similar situations can't afford it.

  Health

  Feb 2, 2018